New Therapies Bring New Hope for Lymphoma Patients: Dr. Rahul Bhargava
New Delhi [India], March 17: Recent advances in cancer treatment are transforming the outlook for patients with lymphoma, offering renewed hope where options were once limited. According to Dr. Rahul Bhargava, one of India’s leading hematologists and stem cell transplant specialists, newer treatments such as CAR-T cell therapy and BiTE (Bispecific T-cell Engager) therapy are redefining outcomes for patients with relapsed or refractory lymphoma.
“For decades, lymphoma treatment relied largely on chemotherapy, monoclonal antibodies, and targeted therapies,” says Dr. Bhargava. “These treatments helped control the disease and extended life expectancy for many patients. However, nearly 40% of patients would still experience relapse despite receiving the best available therapies, leaving them wi...